Business Context and Reporting Period
This Form 8-K Current Report was filed by GE Healthcare Technologies Inc. on August 13, 2026. The filing discloses a significant executive leadership change regarding the appointment of a new Chief Financial Officer.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on executive compensation and appointment details.
Material Changes
The primary material change is the appointment of William K. Grogan as Chief Financial Officer, effective September 14, 2026. George A. Newcomb will cease serving as interim CFO on that date but will continue as Controller and Chief Accounting Officer.
Management Commentary and Compensation Details
The Board approved Mr. Grogan's compensation package, which includes the following components:
- Base Salary: $900,000 annually.
- Target Annual Bonus: 100% of base salary.
- Annual Long-Term Incentive (LTI): Target grant date value of $3,300,000, consisting of 50% performance stock units, 25% restricted stock units (RSUs), and 25% stock options.
- Cash Sign-On Payment: $550,000 to offset forfeited 2026 annual bonus from his prior employer, subject to repayment if he resigns within two years or is terminated for cause.
- One-Time Sign-On Equity Award: $4,000,000 in RSUs to offset forfeited pre-2026 LTI from his prior employer, vesting 50% on the first anniversary and 50% on the second anniversary.
Mr. Grogan previously served as CFO of Xylem Inc. (since October 2023) and IDEX Corporation (2017–2023).
Investor Verification Checklist
- Verify the effective start date of September 14, 2026, for the new CFO.
- Confirm the repayment terms for the $550,000 cash sign-on payment in the event of early resignation.
- Review the full offer letter to be filed in the Form 10-Q for the quarter ended September 30, 2026, for complete terms.
- Monitor the transition of duties from interim CFO George A. Newcomb.